Comparative evaluation of 99mTc GH, 99mTcO4, and 99mTc DTPA as brain imaging agents.
The brain imaging properties of 99mTc glucoheptonate, 99mTc pertechnetate, and 99mTc DPTA are compared. Results demonstrate that optimum images are obtained at 90, 180, and 180 min., for 99mTc GH, 99mTc DTPA, and 99mTc perterchnetate, respectively. The former two images are not affected by prior bone imaging with 99mTc pyrophosphate, while 99mTc pertechnetate images are adversely affected. 99mTc glucoheptonate appears to be the superior agent for brain imaging, followed by 99mTc DTPA and 99mTc pertechnetate.
D001927:Brain Diseases / Q000175:diagnosis*; D001932:Brain Neoplasms / Q000175:diagnosis; D003951:Diagnostic Errors; D006539:Heptoses; D006801:Humans; D008297:Male; D008875:Middle Aged; D004369:Pentetic Acid; D011877:Radionuclide Imaging; D013400:Sugar Acids; D013667:Technetium; D013997:Time Factors
D006539:Heptoses; D013400:Sugar Acids; D013667:Technetium; D004369:Pentetic Acid